PALB2 p.Pro661Arg
c.1982C>G · rs71379822 · VCV232550
Computational evidence
| Protein change | ||
| AlphaMissense | 0.1263 | likely benign |
|---|---|---|
| REVEL | 0.101 | moderately benign-leaning |
| SaProt | LLR -6.41 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 2.1 | GERP 1.9, phastCons 0.88 |
| Regional constraint | o/e 1.00 | unconstrained · MANE · 38 kb · p 0.87 · regional, not allelic |
| Overall | ||
| CADD | 19.39 | PHRED · no single calibrated threshold — expert panels disagree |
ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
Absent from gnomAD v4.1. Not observed in any sequenced alleles — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.
Variant & gene context
- Gene
- PALB2
- Protein
- p.Pro661Arg
- Coding
- c.1982C>G
- MANE Select
- NM_024675
- dbSNP
- rs71379822
- Type
- single nucleotide variant
- Location
- chr16:23630172 (GRCh38)
- Gene constraint
- LOEUF 0.9 · pLI <0.01 · ClinGen HI 3/3 (gnomAD)
- Structure
- AlphaFold pLDDT 54.07 · 4 PDB
- Residue 661
- a UniProt-annotated variant site (risk factor for brovca5); a UniProt-annotated variant site (in fancn; risk factor for brovca5)
Disease context
familial pancreatic carcinoma — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: Fanconi anemia complementation group Npancreatic cancer, susceptibility to, 3hereditary neoplastic syndromehereditary breast carcinoma
For Familial pancreatic carcinoma (Orphanet):
- Inheritance
- Autosomal dominant, Multigenic/multifactorial
- Onset
- Adult
- Prevalence
- 1-9 / 1 000 000 (Europe)
Similar variants
- PALB2 p.Pro661= Benign/Likely benign ★★ same residue
- PALB2 p.Pro661Ser Uncertain significance ★ ⚠ same residue
- PALB2 p.Pro661Leu Likely benign ★ same residue
- PALB2 p.Pro661fs Pathogenic/Likely pathogenic ★★ same residue
- PALB2 c.3350+4A>G Likely pathogenic ★★★ same condition
- PALB2 p.Arg1117Lys Pathogenic ★★★ ⚠ same condition
- PALB2 p.Gln228Ter Pathogenic ★★★ same condition
- PALB2 p.Gln692Ter Likely pathogenic ★★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/palb2-p-pro661arg (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown